I now have very comprehensive content from multiple authoritative textbooks. I have enough to write a thorough response. Let me compile everything into a well-structured answer.
Management of Acute Pancreatitis
Acute pancreatitis (AP) is a common GI emergency with a wide severity spectrum. Mild disease is self-limited (mortality <1%), while severe/critical disease carries mortality of 20-50%+. Management is centered on risk stratification, aggressive fluid resuscitation, pain control, nutritional support, and managing local and systemic complications.
1. Classification of Severity
The Revised Atlanta Classification defines three tiers based on organ failure and local complications:
| Severity | Definition | Mortality |
|---|
| Mild | No organ failure, no local/systemic complications | <1% |
| Moderately severe | Transient organ failure (<48 h) OR local/systemic complications without persistent organ failure | Low |
| Severe | Persistent organ failure (>48 h), one or more organs | 20-40% |
| Critical | Persistent organ failure + infected necrosis | >50% |
Scoring systems used at 24h include:
- BISAP score (≥3 = high risk): BUN >25 mg/dL, Impaired mental status (GCS <15), SIRS, Age >60, Pleural effusion
- APACHE II score ≥8 at 24h
- Modified Marshall score for organ failure (CV: SBP <90 or HR >130; Pulmonary: PaO2 <60 mmHg; Renal: creatinine >2.0 mg/dL)
- Hematocrit >44% and admission BUN >20 mg/dL predict severity
- CRP >100 mg/L (typically peaks at 48-72h) is a useful hospitalization marker
Patients with persistent SIRS at 24h, high BISAP scores, or evidence of organ failure should be triaged to ICU or step-down unit. Early transfer to a specialized center is an important priority. - Harrison's, p. 2791
2. Initial Assessment and Resuscitation
Fluid Resuscitation
Fluid therapy to restore and maintain circulating blood volume is the most important early intervention.
- Use balanced crystalloid (lactated Ringer's solution preferred over normal saline - shown to reduce the systemic inflammatory response)
- Rate: aim to restore normal BP, blood volume, and urine output; some centers use 5-10 mL/kg/hr in the first 24h, but tailor to the patient
- Monitor: BUN and hematocrit should fall in the first 12-24h as confirmation of adequate resuscitation; a rising BUN is associated with higher in-hospital mortality
- Caution with aggressive resuscitation in cardiac, renal, or elderly patients (risk of over-resuscitation and abdominal compartment syndrome)
Analgesia
- Adequate analgesia is a core requirement; IV opioids (morphine, hydromorphone, fentanyl) are standard for moderate-severe pain
- Epidural analgesia may be used in severe cases
- NSAIDs and acetaminophen can supplement
Monitoring (in severe AP)
Admit to HDU/ICU with:
- Invasive vital signs monitoring
- Central venous pressure
- Hourly urine output
- Serial ABGs
- Frequent labs: FBC, LFTs, renal function, clotting, serum calcium, blood glucose - Bailey & Love's, p. 1294
3. Determining Etiology
- Gallstones: USS abdomen (gallstones are the cause in ~40% of cases); elevated ALP >300 IU/L, ALT >100 IU/L, amylase >4000 IU/L suggest biliary etiology
- Alcohol: confirm with blood ethanol levels
- Other: serum triglycerides, calcium (hyperparathyroidism, malignancy), full drug history, ERCP history, trauma, infection
- For idiopathic AP: consider EUS, MRCP, genetic testing (CFTR, SPINK1, PRSS1 mutations)
4. Nutritional Support
Historically, "pancreatic rest" (NPO) was standard - this is no longer appropriate.
- Mild AP: Oral low-fat solid diet once able to eat; resuming intake ad libitum (patient-controlled) is safe and preferred - no need to wait for pain resolution or amylase normalization
- Moderate-severe AP: Start enteral nutrition (EN) within 24-72h of admission
- Gastric feeding (nasogastric tube) is safe; nasojejunal feeding if intolerant
- Advance in stepwise fashion over 2-3 days
- Aggressive early enteral feeding before adequate resuscitation risks non-occlusive mesenteric ischemia
- Parenteral nutrition (TPN): Use only if enteral route is not achievable; TPN is more expensive, riskier, and not more effective than EN
- No evidence for elemental or immune-enhancing formulas over standard polymeric formulas - Schwartz's Surgery, p. 1471
5. Antibiotics
No prophylactic antibiotics in acute pancreatitis, including in necrotizing pancreatitis - current guidelines consistently recommend against this:
"Prophylactic antibiotics are no longer recommended for severe acute pancreatitis... Prophylactic antibiotics do not lead to improved survival and may promote the development of opportunistic fungal infections." - Harrison's, p. 2791
- Antibiotics indicated when:
- Confirmed or strongly suspected infected necrosis (fever, rising WBC, gas in necrotic collection on CT)
- Cholangitis (see ERCP below)
- Concomitant respiratory or urinary tract infection
- Regimens used: IV cefuroxime, imipenem, or ciprofloxacin + metronidazole
- Duration should not exceed 14 days; guide further use with microbiology cultures
6. Imaging
- Ultrasound: First-line for etiology (gallstones); not reliable for grading pancreatitis severity
- Contrast-enhanced CT (CECT): Gold standard for local complications
- Best performed 3-5 days after onset if patient is not responding to supportive care
- Avoid routine CT within 72h (overutilized in mild disease)
- Defines interstitial vs. necrotizing pancreatitis; guides drainage procedures
- Perform urgently if: organ failure, clinical deterioration, or signs of sepsis develop
- MRI/MRCP: Superior to CT for detecting solid content within collections and pancreatic duct disruption; preferred if bleeding is suspected alongside a collection
- CT Severity Index (Balthazar scoring) correlates with morbidity and mortality
CT Morphology of Local Collections (Revised Atlanta)
| Type | Timing | Content | Infection Status |
|---|
| Acute Pancreatic Fluid Collection (APFC) | <4 weeks | Fluid | Sterile/Infected |
| Pseudocyst | >4 weeks | Fluid, defined wall | Sterile/Infected |
| Acute Necrotic Collection (ANC) | <4 weeks | Solid ± fluid | Sterile/Infected |
| Walled-Off Necrosis (WON) | >4 weeks | Solid ± fluid, defined wall | Sterile/Infected |
- Schwartz's Surgery, p. 1471
7. ERCP in Acute Pancreatitis
- Indicated within 72 hours for:
- Predicted or proven severe gallstone pancreatitis
- Signs of jaundice, cholangitis, or dilated common bile duct
- Sphincterotomy + bile duct clearance reduces infective complications
- In cholangitis, sphincterotomy or biliary stenting is mandatory
- ERCP is not indicated for mild gallstone pancreatitis without cholangitis or ductal obstruction
- Note: ERCP carries a small risk of worsening pancreatitis
8. Management of Local Complications
Sterile Necrosis
- Managed conservatively in the majority of cases unless complications arise (hemorrhage, abdominal compartment syndrome, fistula)
- Multidisciplinary team (gastroenterology, surgery, interventional radiology, ICU) essential
- Consider transfer to a tertiary pancreas center
Infected Necrosis (Definitive Management)
The step-up approach is the current treatment paradigm, replacing open necrosectomy as the historical default:
Step 1 - Antibiotics: Target organisms once culture-confirmed
Step 2 - Drainage (if antibiotics insufficient):
- Endoscopic transmural drainage (EUS-guided) preferred - introduced transgastrically or transduodenally
- Percutaneous drainage if collection not amenable to endoscopic approach
Step 3 - Debridement/Necrosectomy (if drainage insufficient):
- Endoscopic necrosectomy (direct endoscopic necrosectomy - DEN) via transgastric approach
- Video-assisted retroperitoneal debridement (VARD) or minimally invasive retroperitoneal necrosectomy
- Open necrosectomy: reserved as last resort - historically associated with 34-95% morbidity and 11-39% mortality
"The TENSION trial (2018) compared the endoscopic step-up approach (EUS-guided transluminal drainage followed by endoscopic necrosectomy if necessary) with the surgical step-up approach and found equivalent outcomes with a lower rate of complications with the endoscopic approach." - Current Surgical Therapy 14e
"A step-up approach (percutaneous or endoscopic transgastric/transduodenal drainage followed, if necessary, by endoscopic or, rarely, surgical necrosectomy) is the current treatment paradigm. Randomized trials have reported advantages..." - Harrison's, p. 2792
Timing: Drain/debride infected WON, ideally after it has matured (>4 weeks from onset) - delaying intervention reduces complications
Pseudocysts
- Most resolve spontaneously; intervention only for symptomatic/enlarging/infected pseudocysts
- Endoscopic transmural drainage (EUS-guided cystogastrostomy) is first-line for suitable anatomy
9. Systemic Complications Management
| Complication | Management |
|---|
| Respiratory failure / ARDS | Mechanical ventilation, supplemental oxygen |
| Hemodynamic instability | IV fluid resuscitation, vasopressors (noradrenaline first-line) |
| Renal failure | Hemofiltration (CRRT preferred in ARF) |
| DIC / Coagulopathy | FFP, platelets, cryoprecipitate |
| Hyperglycemia | Insulin infusion (target glucose 140-180 mg/dL) |
| Hypocalcemia | IV calcium gluconate |
| Abdominal compartment syndrome | Decompressive laparotomy if conservative measures fail |
- Bailey & Love's, p. 1295
10. Definitive Treatment - Prevention of Recurrence
| Etiology | Definitive Treatment |
|---|
| Gallstone pancreatitis | Cholecystectomy (during same admission for mild AP, after 6 weeks for severe AP) |
| Alcoholic pancreatitis | Abstinence from alcohol |
| Hypertriglyceridemia | Triglyceride-lowering agents, dietary modification, insulin infusion (acutely); fenofibrate/omega-3 FA (maintenance) |
| Hypercalcemia | Treat underlying cause (parathyroidectomy, etc.) |
| Drug-induced | Discontinue causative drug |
| Post-ERCP pancreatitis | Rectal indomethacin + prophylactic pancreatic duct stenting before ERCP |
Summary Algorithm
Acute Pancreatitis Suspected
↓
Confirm diagnosis (lipase/amylase >3x ULN ± imaging)
↓
Risk stratify: BISAP, SIRS, BUN, Hematocrit, Organ failure
↓
┌────────────────┬────────────────────────────┐
│ MILD AP │ MODERATE-SEVERE/CRITICAL │
│ (no OF, no │ (persistent OF >48h or │
│ local comps) │ necrosis/collections) │
│ │ │
│ IV fluids (LR) │ ICU/HDU admission │
│ Analgesia │ Aggressive fluid resus. │
│ Oral diet when │ Enteral nutrition (24-72h) │
│ tolerating │ NO prophylactic ABx │
│ USS for etiol. │ CECT at 3-5d │
│ Cholecystectomy│ Step-up approach for │
│ before d/c │ infected necrosis │
│ │ ERCP if cholangitis │
└────────────────┴────────────────────────────┘
Key sources: Harrison's Principles of Internal Medicine 22E (2025); Schwartz's Principles of Surgery 11E; Bailey & Love's Short Practice of Surgery 28E; Current Surgical Therapy 14E.